MedPath

FEXOFENADINE HYDROCHLORIDE

Allergy Relief Fexofenadine Hydrochlroride Tablets 180 mg

Approved
Approval ID

ec55732c-a3db-4445-a06d-0f98b21ed134

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Jun 9, 2025

Manufacturers
FDA

NUVICARE LLC

DUNS: 119257565

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FEXOFENADINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code84324-008
Application NumberANDA210137
Product Classification
M
Marketing Category
C73584
G
Generic Name
FEXOFENADINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateJune 9, 2025
FDA Product Classification

INGREDIENTS (12)

FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FEXOFENADINE HYDROCHLORIDEActive
Quantity: 180 mg in 1 1
Code: 2S068B75ZU
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 6/9/2025

![PP0133-01 NC(nosymbol)-Allergy Relief- Fexo-4ct_page-0001](/dailymed/image.cfm?name=PP0133-01+NC%28nosymbol%29-Allergy+Relief- Fexo-4ct_page-0001.jpg&id=880411)

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 6/9/2025

Uses

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
 runny nose  sneezing  itchy, watery eyes  itching of the nose or throat

WARNINGS SECTION

LOINC: 34071-1Updated: 6/9/2025

Warnings

OTC - DO NOT USE SECTION

LOINC: 50570-1Updated: 6/9/2025

Do not useif you have ever had an allergic reaction to this product or any of its ingredients.

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 6/9/2025

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 6/9/2025

Active ingredient (in each tablet)

Fexofenadine HCl 180 mg

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 6/9/2025

Purpose

Antihistamine

OTC - ASK DOCTOR SECTION

LOINC: 50569-3Updated: 6/9/2025

Ask a****doctor before use if you havekidney disease. Your doctor should determine if you need a different dose.

OTC - WHEN USING SECTION

LOINC: 50567-7Updated: 6/9/2025

When using this product do not take more than directed  do not take at
the same time as aluminum or magnesium antacids  do not take with fruit juices**(see Directions)**

OTC - STOP USE SECTION

LOINC: 50566-9Updated: 6/9/2025

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

LOINC: 53414-9Updated: 6/9/2025

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 6/9/2025

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 6/9/2025

Directions

adults and children 12 years of age and over

take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours

children under 12 years of age

do not use

adults 65 years of age and older

ask a doctor

consumers with kidney disease

ask a doctor

OTHER SAFETY INFORMATION

LOINC: 60561-8Updated: 6/9/2025

Other information store between 20º and 25ºC (68º and 77ºF)  protect from excessive moisture

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 6/9/2025

**Inactive ingredients:**colloidal silicone dioxide, croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol/macrogol, povidone, pregelatinized starch, red iron oxide, silica, titanium dioxide, yellow iron oxide.

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 6/9/2025

Call 1(718) 337-8733 or visit: support@nuvicare.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.